Skip to main content

Table 1 Clinical characteristics of patients with KOA included in this study

From: Effectiveness and safety of multiple injections of human placenta-derived MSCs for knee osteoarthritis: a nonrandomized phase I trial

Parameter

Control group (n = 11)

MSC group (n = 15)

p value

Age, years, mean (range)

61.5 (32–69)

53.9 (24–72)

0.146

Gender, n (%)

  

0.61

 Male

 Female

4/11 (36.36%)

7/11 (63.64%)

5/15 (33.33%)

10/15 (66.67%)

 

BMI (kg/m2), mean (± SD)

  

0.285

 < 30

 > 30

28.3 (± 1.5)

6

5

30.4 (± 1.2)

7

8

 

Kellgren grade, n (%)

  

0.624

 II

 III

3/11 (27.27%)

8/11 (72.78%)

5/15 (33.33%)

10/15 (66.67%)

 

WOMAC, mean

35.7

31.0

0.502

VAS 0–100, mm, mean

4.77

4.74

0.96